BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 31612307)

  • 1. Autologous hematopoietic cell transplantation for acute myeloid leukemia in adults: 25 years of experience in Japan.
    Yanada M; Takami A; Mizuno S; Mori J; Chou T; Usuki K; Uchiyama H; Amano I; Fujii S; Miyamoto T; Saito T; Kamimura T; Ichinohe T; Fukuda T; Okamoto S; Atsuta Y; Yano S
    Int J Hematol; 2020 Jan; 111(1):93-102. PubMed ID: 31612307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autologous hematopoietic cell transplantation for acute promyelocytic leukemia in second complete remission: outcomes before and after the introduction of arsenic trioxide.
    Yanada M; Yano S; Kanamori H; Gotoh M; Emi N; Watakabe K; Kurokawa M; Nishikawa A; Mori T; Tomita N; Murata M; Hashimoto H; Henzan H; Kanda Y; Sawa M; Kohno A; Atsuta Y; Ichinohe T; Takami A
    Leuk Lymphoma; 2017 May; 58(5):1061-1067. PubMed ID: 27701911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autologous hematopoietic cell transplantation during second or subsequent complete remission of acute promyelocytic leukemia: a prognostic factor analysis.
    Yanada M; Ota S; Mukae J; Nara M; Kako S; Nishikawa A; Uchida N; Sawa M; Nakano N; Onizuka M; Kanda Y; Ichinohe T; Atsuta Y; Yano S
    Bone Marrow Transplant; 2022 Jan; 57(1):78-82. PubMed ID: 34645925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autologous is superior to allogeneic hematopoietic cell transplantation for acute promyelocytic leukemia in second complete remission.
    Holter Chakrabarty JL; Rubinger M; Le-Rademacher J; Wang HL; Grigg A; Selby GB; Szer J; Rowe JM; Weisdorf DJ; Tallman MS
    Biol Blood Marrow Transplant; 2014 Jul; 20(7):1021-5. PubMed ID: 24691221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of hematopoietic stem cell transplantation for relapsed acute promyelocytic leukemia: a retrospective analysis of JALSG-APL97.
    Fujita H; Asou N; Iwanaga M; Hyo R; Nomura S; Kiyoi H; Okada M; Inaguma Y; Matsuda M; Yamauchi T; Ohtake S; Izumi T; Nakaseko C; Ishigatsubo Y; Shinagawa K; Takeshita A; Miyazaki Y; Ohnishi K; Miyawaki S; Naoe T;
    Cancer Sci; 2013 Oct; 104(10):1339-45. PubMed ID: 23837667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allogeneic hematopoietic cell transplantation for adults with acute myeloid leukemia conducted in Japan during the past quarter century.
    Yanada M; Takami A; Yamasaki S; Arai Y; Konuma T; Uchida N; Najima Y; Fukuda T; Tanaka M; Ozawa Y; Ikegame K; Takanashi M; Ichinohe T; Okamoto S; Atsuta Y; Yano S
    Ann Hematol; 2020 Jun; 99(6):1351-1360. PubMed ID: 32363416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Term Outcome of Autologous Hematopoietic Stem Cell Transplantation (AHSCT) for Acute Myeloid Leukemia (AML)- Single Center Retrospective Analysis.
    Helbig G; Koclęga A; Woźniczka K; Kopera M; Kyrcz-Krzemień S
    Pathol Oncol Res; 2018 Jul; 24(3):469-475. PubMed ID: 28660547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allogeneic Hematopoietic Cell Transplantation for Patients with Relapsed Acute Promyelocytic Leukemia.
    Yanada M; Matsuda K; Ishii H; Fukuda T; Ozeki K; Ota S; Tashiro H; Uchida N; Kako S; Doki N; Kawakita T; Onishi Y; Takada S; Kondo Y; Tanaka J; Kanda Y; Atsuta Y; Yano S
    Transplant Cell Ther; 2022 Dec; 28(12):847.e1-847.e8. PubMed ID: 36179987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes in patients with relapsed or refractory acute promyelocytic leukemia treated with or without autologous or allogeneic hematopoietic stem cell transplantation.
    Pemmaraju N; Tanaka MF; Ravandi F; Lin H; Baladandayuthapani V; Rondon G; Giralt SA; Chen J; Pierce S; Cortes J; Kantarjian H; Champlin RE; De Lima M; Qazilbash MH
    Clin Lymphoma Myeloma Leuk; 2013 Aug; 13(4):485-92. PubMed ID: 23769669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allogeneic hematopoietic cell transplantation in adult acute myeloid leukemia with 11q23 abnormality: a retrospective study of the Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT).
    Konuma T; Mizuno S; Kondo T; Yamaguchi H; Fukuda T; Uchida N; Najima Y; Kanamori H; Ota S; Nakamae H; Nakamae M; Mizuno I; Sugita J; Onishi Y; Yokota A; Takahashi S; Kanda Y; Ichinohe T; Atsuta Y; Yano S;
    Ann Hematol; 2018 Nov; 97(11):2173-2183. PubMed ID: 29978286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Outcome of Autologous Hematopoietic Cell Transplantation in Adult Patients with Acute Myeloid Leukemia: Who May Benefit from Autologous Hematopoietic Cell Transplantation?
    Yoon JH; Kim HJ; Park SS; Jeon YW; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Min WS
    Biol Blood Marrow Transplant; 2017 Apr; 23(4):588-597. PubMed ID: 28089879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autologous transplant remains the preferred therapy for relapsed APL in CR2.
    Ganzel C; Mathews V; Alimoghaddam K; Ghavamzadeh A; Kuk D; Devlin S; Wang H; Zhang MJ; Weisdorf D; Douer D; Rowe JM; Polge E; Esteve J; Nagler A; Mohty M; Tallman MS
    Bone Marrow Transplant; 2016 Sep; 51(9):1180-3. PubMed ID: 27088379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Outcomes for Pediatric Patients With Acute Myeloid Leukemia in Remission and Undergoing Allogeneic Hematopoietic Cell Transplantation With Myeloablative Conditioning Regimens Based on Either Intravenous Busulfan or Total Body Irradiation: A Report From the Japanese Society for Hematopoietic Cell Transplantation.
    Ishida H; Kato M; Kudo K; Taga T; Tomizawa D; Miyamura T; Goto H; Inagaki J; Koh K; Terui K; Ogawa A; Kawano Y; Inoue M; Sawada A; Kato K; Atsuta Y; Yamashita T; Adachi S
    Biol Blood Marrow Transplant; 2015 Dec; 21(12):2141-2147. PubMed ID: 26271192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for outcome in refractory acute myeloid leukemia patients treated with a combination of fludarabine, cytarabine, and amsacrine followed by a reduced-intensity conditioning and allogeneic stem cell transplantation.
    Pfrepper C; Klink A; Behre G; Schenk T; Franke GN; Jentzsch M; Schwind S; Al-Ali HK; Hochhaus A; Niederwieser D; Sayer HG
    J Cancer Res Clin Oncol; 2016 Jan; 142(1):317-24. PubMed ID: 26424692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous busulfan for autologous stem cell transplantation in adult patients with acute myeloid leukemia: a survey of 952 patients on behalf of the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
    Nagler A; Labopin M; Gorin NC; Ferrara F; Sanz MA; Wu D; Gomez AT; Lapusan S; Irrera G; Guimaraes JE; Sousa AB; Carella AM; Vey N; Arcese W; Shimoni A; Berger R; Rocha V; Mohty M
    Haematologica; 2014 Aug; 99(8):1380-6. PubMed ID: 24816236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of Autologous and Allogeneic Hematopoietic Cell Transplantation in Adults with Acute Promyelocytic Leukemia: Results of a Systematic Review and Meta-Analysis.
    Mohty R; Reljic T; Yassine F; Kettaneh C; Al-Husni D; Keller K; Badar T; Murthy H; Foran J; Kumar A; Kharfan-Dabaja MA
    Transplant Cell Ther; 2024 Jun; 30(6):599.e1-599.e10. PubMed ID: 38554737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hematopoietic stem cell transplantation in acute promyelocytic leukemia, experience in Iran.
    Alimoghaddam K; Ghavamzadeh A; Jahani M; Jalali A; Jorjani H; Iravani M; Hamidieh AA; Mousavi A; Bahar B; Behfar M; Derakhshandeh R; Rostami S
    Arch Iran Med; 2011 Sep; 14(5):332-4. PubMed ID: 21888457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
    Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autologous and allogeneic stem-cell transplantation as salvage treatment of acute promyelocytic leukemia initially treated with all-trans-retinoic acid: a retrospective analysis of the European acute promyelocytic leukemia group.
    de Botton S; Fawaz A; Chevret S; Dombret H; Thomas X; Sanz M; Guerci A; San Miguel J; de la Serna J; Stoppa AM; Reman O; Stamatoulas A; Fey M; Cahn JY; Sotto JJ; Bourhis JH; Parry A; Chomienne C; Degos L; Fenaux P
    J Clin Oncol; 2005 Jan; 23(1):120-6. PubMed ID: 15534358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hematopoietic stem cell transplantation for pediatric acute promyelocytic leukemia in Japan.
    Yamamoto S; Tomizawa D; Kudo K; Hasegawa D; Taga T; Yanada M; Kondo T; Nakazawa Y; Eto T; Inoue M; Kato K; Atsuta Y; Ishida H
    Pediatr Blood Cancer; 2020 May; 67(5):e28181. PubMed ID: 31965692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.